SAB BIOTHERAPEUTICS INC

SABSNASDAQ

🏆 #2705 by market capUS Equity

$336.01▼ $18.41 (−5.48%)

Simulated price

1h—

24h▼ 5.5%

7d—

14d—

30d—

1y—

🏦Market Cap

$342M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

260.0x

Expensive

Otter Score

47

Weak

🔭

No analyst ratings for SABS

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.